Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (181-190 of 373) with videos related to

Pageof 38
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 17, 2020
Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: A mixed-methods contextual analysis as part of the SMILe studyLynn Leppla, Juliane Mielke, Maria Kunze, et al.
Haematologica|July 18, 2012
Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cellsAnne-Kathrin Hechinger, Kristina Maas, Christoph Dürr, et al.
Nature Medicine|June 6, 2024
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trialYi-Bin Chen, Mohamad Mohty, Robert Zeiser, et al.
Blood|June 29, 2026
Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistanceEzgi Ozyerli-Goknar, Sheikh Nizamuddin, Viktor Fetsch, et al.
Hemasphere|November 15, 2019
Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid LeukemiaKatharina Sies, Corinna Spohr, Albert Gründer, et al.
Molecular Oncology|October 4, 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancerKerstin Rönsch, Sabine Jägle, Katja Rose, et al.
Frontiers in Immunology|August 1, 2018
P2Y2R Signaling Is Involved in the Onset of GlomerulonephritisLaura Rennert, Stefan Zschiedrich, Lukas Sandner, et al.
Bone Marrow Transplantation|November 26, 2025
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeGiorgia Battipaglia, Claudia Wehr, Rick Admiraal, et al.
Cancer Cell|November 2, 2010
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationKavya Rakhra, Pavan Bachireddy, Tahera Zabuawala, et al.
Bone Marrow Transplantation|August 1, 2025
Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort studyHauke Wilcken, Klaus Kaier, Thomas Meyer, et al.
Pageof 38

Showing results (181-190 of 373) with videos related to

Sort By:
Pageof 38
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 17, 2020
Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: A mixed-methods contextual analysis as part of the SMILe studyLynn Leppla, Juliane Mielke, Maria Kunze, et al.
Haematologica|July 18, 2012
Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cellsAnne-Kathrin Hechinger, Kristina Maas, Christoph Dürr, et al.
Nature Medicine|June 6, 2024
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trialYi-Bin Chen, Mohamad Mohty, Robert Zeiser, et al.
Blood|June 29, 2026
Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistanceEzgi Ozyerli-Goknar, Sheikh Nizamuddin, Viktor Fetsch, et al.
Hemasphere|November 15, 2019
Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid LeukemiaKatharina Sies, Corinna Spohr, Albert Gründer, et al.
Molecular Oncology|October 4, 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancerKerstin Rönsch, Sabine Jägle, Katja Rose, et al.
Frontiers in Immunology|August 1, 2018
P2Y2R Signaling Is Involved in the Onset of GlomerulonephritisLaura Rennert, Stefan Zschiedrich, Lukas Sandner, et al.
Bone Marrow Transplantation|November 26, 2025
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeGiorgia Battipaglia, Claudia Wehr, Rick Admiraal, et al.
Cancer Cell|November 2, 2010
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationKavya Rakhra, Pavan Bachireddy, Tahera Zabuawala, et al.
Bone Marrow Transplantation|August 1, 2025
Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort studyHauke Wilcken, Klaus Kaier, Thomas Meyer, et al.
Pageof 38